Dapoxetine sex medicine

According to Medscape Medical News, Dapoxetine Hydrochloride (Dapoxetine)

http://www.poerkan.com/Dapoxetine-new-sex-medicine-for-premature-ejaculation has been

shown to be effective in all doses for treatment of premature ejaculation. Experts are

hopeful that this promising treatment will do for PE what other hugely popular drugs have

done for erectile dysfunction.

There are many products that claim to help with PE, but this is the first that is simple,

quick and has been proven in scientific studies. Dapoxetine is an easy, on-demand

solution for the 30-70% of men who experience premature ejaculation and are looking for a

way to last longer in bed.

Dapoxetine was developed specifically for enabling men to lengthen the time before

ejaculation. An imbalance in the brain chemical Serotonin has long been believed to be a

factor in rapid ejaculation. Because of this, SSRIs are often used “off label” to treat

men who experience severe premature ejaculation. Dapoxetine is considered a “novel SSRI”,

however,    because unlike many similar medications that take over 2 weeks to become

effective, it starts working within an hour. The drug is is also quickly metabolized by

the body. This eliminates the risk of long term side-effects often associated with other

SSRIs.

Dapoxetine HCL is the first orally administered drug developed specifically for the

treatment of men with premature ejaculation. The safety and effectiveness of Dapoxetine

for the treatment of men with PE were studied in five, double-blind, placebo-controlled,

Phase III clinical trials. These trials involved over 6,000 men from 30 countries

worldwide, including countries in North America, South America, Europe and Asia, and in

Israel and South Africa.

The results of these trials were overwhelmingly positive. It worked and it was shown to

be safe. Men taking the 30mg dose increased time before ejaculation by 308%. For the 60mg

dose, the increase was 369%. Participants in the study took a single dose from 30 minutes

to 4 hours before intercourse. Although rare, the most common side effect was nausea, and

this was more likely to occur with higher doses.

Overall, the men who received Dapoxetine reported greater control over the timing fo

their orgasms, and increased overall satisfaction with the sexual experience. No doubt,

their partners felt the same way.

Regulatory Status of Dapoxetine Dapoxetine HCL has not yet been approved by the US FDA,

but has been proven to be safe for premature ejaculation treatment in numerous studies

worldwide. Many countries outside the US are moving ahead with regulatory submissions and

approvals. Europe, as usual, is leading the charge when it comes to approving new

treatments, and our European friends will probably be enjoying the results of this new   

  treatment for premature ejaculation long before it is readily available in the USA.

Janssen-Cilag companies in Europe have recently submitted a Marketing Authorization

Application (MAA) for Dapoxetine, as a treatment for premature ejaculation (PE) in men

18-64 years of age (December 2007).

The European Marketing Authorization Application for Dapoxetine was submitted under what

is referred to as the “decentralized procedure”, whereby Sweden acts the Reference Member

State and Austria, Finland, Germany, Italy, Portugal and Spain will act as the Concerned

Member States for the application. Regulatory submissions and approvals in other regions

of the world are expected to follow. http://www.poerkan.com

Processing your request, Please wait....